Recent Updates
Recently added Catalysts
COLL

Collegium to Participate in Upcoming Conferences

Key Takeaway: STOUGHTON, Mass., Nov. 11, 2021 (GLOBE NEWSWIRE) -- Collegium Pharmaceutical, Inc. (Nasdaq: COLL), a specialty pharmaceutical company committed to being the leader in responsible pain management, today announced that management will participate in the following investor conferenc
Price reaction · baseline $20.2 (2021-11-10 close) · hit after-hours · 1 other COLL headline(s) in the window, move may be shared
day 0 close · peak
-0.4%

BiopharmaWatch Analysis

From our catalyst data and publicly available data · not financial advice
Best trade, last catalyst
+28%
120-day peak, hindsight
Typical move
0.4%
average across 3 past catalysts
Lead asset
DFN-15 Active
Phase 3 · Migraine Headache

Full Press Release Details

STOUGHTON, Mass., Nov. 11, 2021 (GLOBE NEWSWIRE) -- Collegium Pharmaceutical, Inc. (Nasdaq: COLL), a specialty pharmaceutical company committed to being the leader in responsible pain management, today announced that management will participate in the following investor conferences:
Jefferies London Healthcare Conference
Virtual one-on-one meetings
Date: Thursday, November 18, 2021
Piper Sandler Annual Healthcare Conference 2021
Virtual fireside chat
Date: Wednesday, December 1, 2021
The fireside chat will be webcast and may be accessed from the Investor section of the Company’s website: https://ir.collegiumpharma.com. A replay of the webcast will be available on the Company’s website for approximately 30 days after the event.
About Collegium Pharmaceutical, Inc.
Collegium is a specialty pharmaceutical company committed to being the leader in responsible pain management. Collegium’s headquarters are located in Stoughton, Massachusetts. For more information, please visit the company’s website at www.collegiumpharma.com.
Last updated: Nov 11, 2021